| abstract |
The invention concerns an aminoquinoline-antibiotic hybrid compound of general formula (I): Q-(Y<SUB>1</SUB>)<SUB>p</SUB>-(U)<SUB>p'</SUB>-(Y<SUB>2</SUB>)<SUB>p''</SUB>-A; wherein Q represents an aminoquinoline, (Y<SUB>1</SUB>)<SUB>p</SUB>-(U)<SUB>p'</SUB>-(Y<SUB>2</SUB>)<SUB>p''</SUB> is an optional spacer and A is an antibiotic residue. The invention enables the antibiotic residue activity to be unexpectedly enhanced. |